Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Millar

Showing results (511-520 of 574) with videos related to

Pageof 58
Sort By:
The Journal of Clinical Investigation|August 8, 2013
Transcription factor ATF3 links host adaptive response to breast cancer metastasisChris C Wolford, Stephen J McConoughey, Swati P Jalgaonkar, et al.
Blood|August 26, 1998
A randomized phase-II study of BB-10010 (macrophage inflammatory protein- 1alpha) in patients with advanced breast cancer receiving 5-fluorouracil, adriamycin, and cyclophosphamide chemotherapyM J Clemons, E Marshall, J Dürig, et al.
International Journal of Radiation Oncology, Biology, Physics|November 20, 2015
MicroRNA-Related DNA Repair/Cell-Cycle Genes Independently Associated With Relapse After Radiation Therapy for Early Breast CancerHarriet E Gee, Francesca M Buffa, Adrian L Harris, et al.
The Journal of Steroid Biochemistry and Molecular Biology|October 21, 2006
c-Myc overexpression and endocrine resistance in breast cancerCatriona M McNeil, C Marcelo Sergio, Luke R Anderson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 9, 2018
The Magnitude of Androgen Receptor Positivity in Breast Cancer Is Critical for Reliable Prediction of Disease OutcomeCarmela Ricciardelli, Tina Bianco-Miotto, Shalini Jindal, et al.
Oncogene|March 17, 2009
Cyclin D1b protein expression in breast cancer is independent of cyclin D1a and associated with poor disease outcomeE K A Millar, J L Dean, C M McNeil, et al.
The American Journal of Surgical Pathology|July 7, 2021
SP142 PD-L1 Scoring Shows High Interobserver and Intraobserver Agreement in Triple-negative Breast Carcinoma But Overall Low Percentage Agreement With Other PD-L1 Clones SP263 and 22C3Jia-Min B Pang, Belinda Castles, David J Byrne, et al.
Histopathology|May 13, 2010
High Notch1 protein expression is an early event in breast cancer development and is associated with the HER-2 molecular subtypeSarah J Zardawi, Ibrahim Zardawi, Catriona M McNeil, et al.
International Journal of Cancer|August 14, 2009
Loss of STARD10 expression identifies a group of poor prognosis breast cancers independent of HER2/Neu and triple negative statusNiamh C Murphy, Andrew V Biankin, Ewan K A Millar, et al.
Breast Cancer Research : BCR|December 10, 2016
MCL-1 inhibition provides a new way to suppress breast cancer metastasis and increase sensitivity to dasatinibAdelaide I J Young, Andrew M K Law, Lesley Castillo, et al.
Pageof 58

Showing results (511-520 of 574) with videos related to

Sort By:
Pageof 58
The Journal of Clinical Investigation|August 8, 2013
Transcription factor ATF3 links host adaptive response to breast cancer metastasisChris C Wolford, Stephen J McConoughey, Swati P Jalgaonkar, et al.
Blood|August 26, 1998
A randomized phase-II study of BB-10010 (macrophage inflammatory protein- 1alpha) in patients with advanced breast cancer receiving 5-fluorouracil, adriamycin, and cyclophosphamide chemotherapyM J Clemons, E Marshall, J Dürig, et al.
International Journal of Radiation Oncology, Biology, Physics|November 20, 2015
MicroRNA-Related DNA Repair/Cell-Cycle Genes Independently Associated With Relapse After Radiation Therapy for Early Breast CancerHarriet E Gee, Francesca M Buffa, Adrian L Harris, et al.
The Journal of Steroid Biochemistry and Molecular Biology|October 21, 2006
c-Myc overexpression and endocrine resistance in breast cancerCatriona M McNeil, C Marcelo Sergio, Luke R Anderson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 9, 2018
The Magnitude of Androgen Receptor Positivity in Breast Cancer Is Critical for Reliable Prediction of Disease OutcomeCarmela Ricciardelli, Tina Bianco-Miotto, Shalini Jindal, et al.
Oncogene|March 17, 2009
Cyclin D1b protein expression in breast cancer is independent of cyclin D1a and associated with poor disease outcomeE K A Millar, J L Dean, C M McNeil, et al.
The American Journal of Surgical Pathology|July 7, 2021
SP142 PD-L1 Scoring Shows High Interobserver and Intraobserver Agreement in Triple-negative Breast Carcinoma But Overall Low Percentage Agreement With Other PD-L1 Clones SP263 and 22C3Jia-Min B Pang, Belinda Castles, David J Byrne, et al.
Histopathology|May 13, 2010
High Notch1 protein expression is an early event in breast cancer development and is associated with the HER-2 molecular subtypeSarah J Zardawi, Ibrahim Zardawi, Catriona M McNeil, et al.
International Journal of Cancer|August 14, 2009
Loss of STARD10 expression identifies a group of poor prognosis breast cancers independent of HER2/Neu and triple negative statusNiamh C Murphy, Andrew V Biankin, Ewan K A Millar, et al.
Breast Cancer Research : BCR|December 10, 2016
MCL-1 inhibition provides a new way to suppress breast cancer metastasis and increase sensitivity to dasatinibAdelaide I J Young, Andrew M K Law, Lesley Castillo, et al.
Pageof 58